The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

27 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.EBI
University Of Debrecen
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.EBI
Universit£
In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.EBI
Hokuriku University
Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.EBI
Novo Nordisk
Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene-spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides.EBI
University Of Debrecen
Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.EBI
Applied Science University
Discovery of a series of indan carboxylic acid glycogen phosphorylase inhibitors.EBI
Astrazeneca
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.EBI
Glaxosmithkline
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.EBI
Glaxosmithkline
Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors.EBI
Astellas Pharma
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.EBI
Glaxosmithkline
Synthesis and glycogen phosphorylase inhibitor activity of 2,3-dihydrobenzo[1,4]dioxin derivatives.EBI
University Of Debrecen
Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.EBI
The National Hellenic Research Foundation
Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.EBI
Astrazeneca
Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a.EBI
Glaxosmithkline
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.EBI
Sanofi-Aventis Deutschland
5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.EBI
Pfizer
Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a.EBI
Merck Research Laboratories
A new class of glycogen phosphorylase inhibitors.EBI
Merck Research Laboratories
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.EBI
Merck Research Laboratories
Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.EBI
Pfizer
Biochemical and behavioral characterization of novel methylphenidate analogs.BDB
Mercer University
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.BDB
Merck Research Laboratories
The importance of odorant conformation to the binding and activation of a representative olfactory receptor.BDB
Columbia University
Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis.BDB
University Of Toronto